Neuronetics (STIM)Officer sold ~$5.4K

~$5.4K

Approx. value · 3,485 sh @ $1.55

688K

Holds after · shares reported

Traded

Feb 10, 2026

Filed

Feb 12, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Dec 30, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On December 30, 2025, the Compensation Committee of the Board of Directors of Neuronetics, Inc. (the “Company”) approved cash awards and restricted stock unit incentive compensation awards (“RSUs”) for Steven E. Pfanstiel, the Company’s Executive Vice President, Chief Financial Officer and Treasurer, and W. Andrew Macan, the Company’s Executive Vice President, General Counsel, Chief Compliance Officer and Corporate…”
2. Jan 15, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
3. Feb 10, 2026 · this disclosureInsiderOfficer sold ~$5.4K of STIM shares in the open market

What came next

1. Feb 10, 2026Company filing · Form 8-K · ResultsReported its results
2. Feb 10, 2026InsiderCEO sold ~$64K of STIM shares in the open market
3. Feb 12, 2026Insider · 2 peopleInsiders: 2 sales (~$79K)
4. Feb 23, 2026Company filing · Form 8-K · Executive changeChanged a top executive or board member“On February 23, 2026, the Compensation Committee (the “Compensation Committee”) of the Board of Directors (the “Board”) of Neuronetics, Inc. (the “Company”) approved annual cash incentive compensation awards for Steven E. Pfanstiel, the Company’s Executive Vice President, Chief Financial Officer, and Treasurer, and W. Andrew Macan, the Company’s Executive Vice President, Chief Legal Officer, and Corporate Secretary,…”
5. Feb 26, 2026Insider · 2 peopleInsiders: 2 sales (~$16K)
6. Mar 2, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
7. Mar 4, 2026InsiderOfficer sold ~$816 of STIM shares in the open market
8. Mar 17, 2026Company filing · Form 8-K · Results, Executive changeChanged a top executive or board member, and reported its results (and 1 more item)“On March 12, 2026, the board of directors of the Company appointed Daniel L. Reuvers as the Company’s President and Chief Executive Officer effective on the date that Mr. Reuvers commences employment with the Company, which is expected to be March 23, 2026 (the “Reuvers Start Date”).”
9. Mar 17, 2026Insider · 14 days before an 8-K10% owner purchased ~$616K of STIM shares in the open market
10. Mar 18, 2026Insider · 13 days before an 8-K10% owner purchased ~$820K of STIM shares in the open market
11. Mar 19, 2026Insider · 12 days before an 8-K10% owner purchased ~$599K of STIM shares in the open market
12. Mar 20, 2026Insider · 11 days before an 8-K10% owner purchased ~$239K of STIM shares in the open market
13. Mar 25, 2026Insider · 6 days before an 8-K10% owner purchased ~$175K of STIM shares in the open market
14. Mar 26, 2026Insider · 5 days before an 8-K10% owner purchased ~$36K of STIM shares in the open market
15. Mar 27, 2026Insider · 4 days before an 8-K10% owner purchased ~$675K of STIM shares in the open market
16. Mar 30, 2026Insider · 1 day before an 8-K10% owner purchased ~$482K of STIM shares in the open market
17. Mar 31, 2026Company filing · Form 8-K · Material agreement, RestructuringAnnounced job cuts, closures or a restructuring, and changed a top executive or board member (and 2 more items)“On March 31, 2026, Steven E. Pfanstiel, who has served as Executive Vice President, Chief Financial Officer, and Treasurer since July 15, 2025, informed the Company of his intention to resign on May 1, 2026.”
18. Apr 20, 2026Insider10% owner purchased ~$158K of STIM shares in the open market
19. Apr 21, 2026Insider · 14 days before results10% owner purchased ~$151K of STIM shares in the open market
20. May 5, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Neuronetics

For Neuronetics, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its STIM page.

Other recent filings by William Andrew Macan, EVP, CLO and CS

• SEC Form 4 at Neuronetics (STIM)Mar 6, 2026
• SEC Form 4 at Neuronetics (STIM)Feb 27, 2026
• SEC Form 4 at Neuronetics (STIM)Feb 18, 2026
• SEC Form 4 at Neuronetics (STIM)Feb 18, 2025
• SEC Form 4 at Neuronetics (STIM)Feb 14, 2025

The full history of William Andrew Macan, EVP, CLO and CS is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Neuronetics

• SEC Form 4Aug 17, 2026
• SEC Form 4Aug 17, 2026
• SEC Form 4Jul 15, 2026
• SEC Form 4May 20, 2026
• SEC Form 4May 13, 2026
• SEC Form 4Apr 22, 2026

Everything OQRO holds on this company is on its STIM page.